Loading...
Uploaded by interactiveinvestor on Sep 7, 2011
Human bodies and developing new medicines is big business.As its latest blood-thinning blockbuster, Brilinta, finally hits US pharmacy shelves, is AstraZeneca undervalued or over the hill?
News & Politics
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)